An Interdisciplinary Approach for the Management of the Elderly Multimorbid Patient with Breast Cancer Therapy Induced Cardiac Toxicity
Two papers, prepared by the UOI team, entitled “CARDIOCARE: An integrated platform for the management of elderly multimorbid patients with breast cancer therapy induced cardiac toxicity” and “Risk Stratification for Cardiotoxicity in Breast Cancer Patients: Predicting Early Decline of LVEF After Treatment” were accepted in EMBC 2023 that will be held in Syndey Australia, in July 2023. Really glad to participate!
Highlights
At the CARDIO2026 Congress held in Athens on 18–19 May, the CARDIOCARE project made a strong scientific contribution with a dedicated session showcasing its latest advances in cardio-oncology and patient-centered risk prediction. The special session, titled “From...
On 28 May 2026, the CARDIOCARE consortium successfully hosted the CARDIOCARE Workshop at the Thon Hotel EU in Brussels, bringing together researchers, clinicians, healthcare professionals, policymakers, project partners, and stakeholders from across Europe. The...
Innovative AI, digital health tools, and novel biomarkers are helping advance personalised cardio-oncology care for older breast cancer patients across Europe. The CARDIOCARE project is proud to announce a significant milestone in its mission to improve cardiovascular...